Back to Journals » International Journal of Nanomedicine » Volume 6

Electrospun PGA/gelatin nanofibrous scaffolds and their potential application in vascular tissue engineering

Authors Hajiali H, Shahgasempour S, Naimi-Jamal MR, Peirovi H

Published 27 September 2011 Volume 2011:6 Pages 2133—2141

DOI https://doi.org/10.2147/IJN.S24312

Review by Single-blind

Peer reviewer comments 3

Hadi Hajiali1, Shapour Shahgasempour1, M Reza Naimi-Jamal2, Habibullah Peirovi1
1Nanomedicine and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences; 2Department of Chemistry, Iran University of Science and Technology, Tehran, Iran

Background and methods: In this study, gelatin was blended with polyglycolic acid (PGA) at different ratios (0, 10, 30, and 50 wt%) and electrospun. The morphology and structure of the scaffolds were characterized by scanning electron microscopy, Fourier transform infrared spectroscopy, and differential scanning calorimetry. The mechanical properties were also measured by the tensile test. Furthermore, for biocompatibility assessment, human umbilical vein endothelial cells and human umbilical artery smooth muscle cells were cultured on these scaffolds, and cell attachment and viability were evaluated.
Results: PGA with 10 wt% gelatin enhanced the endothelial cells whilst PGA with 30 wt% gelatin increased smooth muscle cell adhesion, penetration, and viability compared with the other scaffold blends. Additionally, with the increase in gelatin content, the mechanical properties of the scaffolds were improved due to interaction between PGA and gelatin, as revealed by Fourier transform infrared spectroscopy and differential scanning calorimetry.
Conclusion: Incorporation of gelatin improves the biological and mechanical properties of PGA, making promising scaffolds for vascular tissue engineering.

Keywords: polyglycolic acid, gelatin, nanofiber, vascular tissue engineering, biocompatible scaffold
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Embedded nanomicro syringe on chip for molecular therapy

Jalil MA, Suwanpayak N, Kulsirirat K, Suttirak S, Ali J, Yupapin PP

International Journal of Nanomedicine 2011, 6:2925-2932

Published Date: 18 November 2011

Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells

Mura S, Hillaireau H, Nicolas J, Le Droumaguet B, Gueutin C, Zanna S, Tsapis N, Fattal E

International Journal of Nanomedicine 2011, 6:2591-2605

Published Date: 26 October 2011

Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery

Tan Q, Liu WD, Guo CY, Zhai GX

International Journal of Nanomedicine 2011, 6:1621-1630

Published Date: 10 August 2011

Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt

Guan P, Lu Y, Qi J, Niu M, Lian R, Hu F, Wu W

International Journal of Nanomedicine 2011, 6:965-974

Published Date: 4 May 2011

Effect of selected drugs used in asthma treatment on morphology and elastic properties of red blood cells

Anna Zuk, Marta Targosz-Korecka, Marek Szymonski

International Journal of Nanomedicine 2011, 6:249-257

Published Date: 27 January 2011